Literature DB >> 27125490

Incentivizing Organ Donor Registrations with Organ Allocation Priority.

Avraham Stoler1, Judd B Kessler2, Tamar Ashkenazi3, Alvin E Roth4, Jacob Lavee5.   

Abstract

How donor organs are allocated for transplant can affect their scarcity. In 2008, Israel's Parliament passed an Organ Transplantation Law granting priority on organ donor waiting lists to individuals who had previously registered as organ donors. Beginning in November 2010, public awareness campaigns advertised the priority policy to the public. Since April 2012, priority has been added to the routine medical criteria in organ allocation decisions. We evaluate the introduction of priority for registered organ donors using Israeli data on organ donor registration from 1992 to 2013. We find that registrations increased when information about the priority law was made widely available. We find an even larger increase in registration rates in the 2 months leading up to a program deadline, after which priority would only be granted with a 3-year delay. We also find that the registration rate responds positively to public awareness campaigns, to the ease of registration (i.e. allowing for registering online and by phone) and to an election drive that included placing registration opportunities in central voting locations.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  incentive for organ donation; organ allocation; organ donation; organ transplantation; transplant law

Mesh:

Year:  2016        PMID: 27125490     DOI: 10.1002/hec.3328

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  2 in total

1.  Israel's 2008 Organ Transplant Law: continued ethical challenges to the priority points model.

Authors:  Corinne Berzon
Journal:  Isr J Health Policy Res       Date:  2018-03-16

2.  Estimating the effect of focused donor registration efforts on the number of organ donors.

Authors:  James H Cardon; Jordan C Holbrook; Mark H Showalter
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.